{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:21:14Z","timestamp":1794975674408,"version":"4.9.1"},"reference-count":33,"publisher":"Wiley","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital"},{"name":"Finska L\u00e4kares\u00e4llskapet), Kidney Foundation in Finland"},{"name":"Medical foundation of Vaasa"},{"name":"Jussi Lall\u2019s and Eeva Meripori-Lall\u2019s Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Nephrology"],"published-print":{"date-parts":[[2018,10,16]]},"abstract":"<jats:p><jats:italic>Aim<\/jats:italic>. We describe the clinical pattern of ANCA-associated vasculitis (AAV) and assess long-term prognostic factors of patients and renal survival and relapse.<jats:italic> Methods<\/jats:italic>. Data from 85 patients with renal biopsy-proven AAV at a single center with up to 20-year [median 16.2 years (95% CI 14.9-17.7)] follow-up were retrospectively collected.<jats:italic> Results<\/jats:italic>. Overall, 55% of the patients had microscopic polyangiitis (MPA) and 45% had granulomatosis with polyangiitis (GPA). The histopathological classes were focal in 35%, crescentic in 26%, mixed in 20%, and sclerotic glomerulonephritis in 19% of the patients. As induction treatment, a combination of cyclophosphamide and corticosteroids was given to 82%, while a combination of azathioprine and corticosteroids was maintenance therapy in 79%. The twenty-year patient survival was 45%. In a multivariable analysis, age \u226558 years [hazard ratio (HR) 7.64, 95% CI 3.44-16.95] and myeloperoxidase (MPO) ANCA (HR 2.12, 95% CI 1.08-4.17) were associated with shorter patient survival time. Renal survival was 68% overall: 88% in focal, 71% in crescentic, 56% in mixed, and 37% in sclerotic class (p=0.01). Female sex (HR 0.26, 95% CI 0.10-0.73) was a predictor of improved renal survival, whereas GFR &lt;30 ml\/min and MPO-ANCA were associated with worse renal survival (HR 4.10, 95% CI 1.35-12.49 and HR 3.10, 95% CI 1.21-7.95, respectively). Relapse-free survival at 20 years was 10%. MPA was associated with a lower risk for relapse (HR 0.48, 95% CI 0.28\u20130.82).<jats:italic> Conclusion<\/jats:italic>. We confirmed the improved patient and renal survival in AAV patients with glomerulonephritis, while relapse remained the primary challenge. Histopathological classification may be relevant for survival.<\/jats:p>","DOI":"10.1155\/2018\/6369814","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T19:31:17Z","timestamp":1539718277000},"page":"1-11","source":"Crossref","is-referenced-by-count":48,"title":["Prognostic Factors for Survival and Relapse in ANCA-Associated Vasculitis with Renal Involvement: A Clinical Long-Term Follow-Up Study"],"prefix":"10.1155","volume":"2018","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6487-3666","authenticated-orcid":true,"given":"Anna","family":"Salmela","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Vaasa Central Hospital, Vaasa, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"T\u00f6rnroth","sequence":"additional","affiliation":[{"name":"Department of Pathology, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Poussa","sequence":"additional","affiliation":[{"name":"STAT-Consulting, Nokia, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Ekstrand","sequence":"additional","affiliation":[{"name":"Abdomen Center, Nephrology, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh522"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010050477"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr643"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu084"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu237"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00025-8"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137778"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197311000-00002"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-9-200511010-00005"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq244"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054593"},{"key":"12","first-page":"1","volume":"65","year":"2013","journal-title":"Arthritis Rheum"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a068882"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.2.170"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep304"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1080\/03009740802238366"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs428"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012090912"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-125"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.08.025"},{"issue":"2","key":"22","first-page":"S-56","volume":"33","year":"2015","journal-title":"Clinical and Experimental Rheumatology"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3195-z"},{"key":"24","first-page":"S105","volume":"34","year":"2016","journal-title":"Clinical and Experimental Rheumatology"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04800516"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5653612"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv008"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-1888-8"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1002\/art.39614"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08290813"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201750"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1002\/art.33361"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1404231"}],"container-title":["International Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijn\/2018\/6369814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijn\/2018\/6369814.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ijn\/2018\/6369814.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T19:31:24Z","timestamp":1539718284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ijn\/2018\/6369814\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":33,"alternative-id":["6369814","6369814"],"URL":"https:\/\/doi.org\/10.1155\/2018\/6369814","relation":{},"ISSN":["2090-214X","2090-2158"],"issn-type":[{"value":"2090-214X","type":"print"},{"value":"2090-2158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]}}}